Please login to the form below

Not currently logged in
Email:
Password:

Martin Reeves joins Oxford BioDynamics

He takes up a senior vice president role

Martin ReevesOxford BioDynamics – a spin out company from the University of Oxford – has appointed Martin Reeves as its new senior vice president, commercial development.

His career to date has seen him hold positions such as head of business development, global branded products at Teva Pharmaceuticals, VP of business development and strategic planning at Cephalon and various project management roles at Wyeth-Ayerst and SmithKline Beecham.

Christian Hoyer Millar, CEO at Oxford BioDynamics, said: “His considerable experience in business development within the sector will be a great asset to Oxford BioDynamics as we look to leverage IP licensing opportunities with our award-winning, proprietary technology platform EpiSwitch.”

23rd March 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fendix

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics